SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-213159
Filing Date
2019-08-06
Accepted
2019-08-05 18:52:38
Documents
1
Group Members
BLACKSTONE CLARUS III L.L.C.BLACKSTONE GROUP INC.BLACKSTONE GROUP MANAGEMENT L.L.C.BLACKSTONE HOLDINGS I/II GP L.L.C.BLACKSTONE HOLDINGS II L.P.CLARUS VENTURES III GP, L.P.STEPHEN A. SCHWARZMAN

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D d787763dsc13da.htm SC 13D/A 172598
  Complete submission text file 0001193125-19-213159.txt   174550
Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences III, L.P. (Filed by) CIK: 0001597143 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1214
Type: SC 13D/A

Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Subject) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90532 | Film No.: 191000017
SIC: 2836 Biological Products, (No Diagnostic Substances)